Omnicell Inc (OQ:OMCL)

Business Focus: Medical Software & Technology Services

Apr 16, 2024 04:01 pm ET
Omnicell Announces XT Amplify
Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell’s XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.
Apr 08, 2024 04:01 pm ET
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.
Mar 11, 2024 05:11 pm ET
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m. ET.
Feb 08, 2024 08:00 am ET
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its fiscal year and fourth quarter ended December 31, 2023.
Jan 16, 2024 04:01 pm ET
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2023, before market open on Thursday, February 8, 2024. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.
Jan 11, 2024 04:00 pm ET
Omnicell Elects Eileen Voynick to Board of Directors
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024. Ms. Voynick fills the vacancy resulting from Sara J. White, a Class I director who stepped down from the Company’s Board of Directors, effective January 5, 2024. In addition, the Company announced that Vance Moore will not stand for reelection to the Company’s Board at Omnicell’s 2024 annual meeting of stockholders (the “2024 annual meeting”) and effective as of the 202
Nov 27, 2023 09:32 am ET
Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00 p.m. ET.
Nov 02, 2023 08:10 am ET
Baptist Health Engages Omnicell in an Effort to Enhance Pharmacy Care and Further Gain Control of Medication Supply Chain
Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming the pharmacy care delivery model, today announced that Kentucky-based Baptist Health has selected Omnicell’s Central Pharmacy Dispensing Service in an effort to address labor challenges and improve clinical and financial outcomes.
Nov 02, 2023 08:01 am ET
Omnicell Announces Third Quarter 2023 Results; Updates Fiscal Year 2023 Guidance and Announces Reduction in Force
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its third quarter ended September 30, 2023.
Oct 16, 2023 04:01 pm ET
Omnicell to Release Third Quarter 2023 Financial Results on November 2, 2023
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter 2023, before market open on Thursday, November 2, 2023. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.
Aug 23, 2023 04:01 pm ET
Omnicell to Present at the 2023 Wells Fargo Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023 at 3:00 p.m. ET.
Aug 01, 2023 04:01 pm ET
Omnicell Announces Second Quarter 2023 Results
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its second quarter ended June 30, 2023.
Jul 12, 2023 04:01 pm ET
Omnicell to Release Second Quarter 2023 Financial Results on August 1, 2023
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter 2023, after market close on Tuesday, August 1, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day.
Jul 11, 2023 08:30 am ET
Omnicell Appoints Bobby Ghoshal to Board of Directors
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced it has increased its number of board seats from 9 to 10, and has appointed Kaushik “Bobby” Ghoshal to fill the newest seat as an independent director of Omnicell’s Board of Directors, effective immediately.
Jun 01, 2023 03:00 pm ET
EmpiRx Health Names Healthcare and Technology Veteran Danny Sanchez as CEO
Sanchez, Who Joined EmpiRx Health Earlier this Year as President, Assumes CEO Role – Reinforces Commitment to Company's Healthcare Mission
May 30, 2023 04:01 pm ET
Omnicell Announces Leadership and Organizational Changes
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced changes to its leadership structure designed to create a more streamlined organization with a continued focus on operational excellence, driving continuous improvements in customer experience and the delivery of Omnicell’s long-term commitments.
May 15, 2023 04:01 pm ET
Omnicell Appoints Nchacha E. Etta as Executive Vice President and Chief Financial Officer
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that Nchacha E. Etta has been appointed Executive Vice President and Chief Financial Officer of the Company, effective June 1, 2023. Mr. Etta succeeds Peter J. Kuipers, who, as previously announced, will be stepping down from his role as Executive Vice President and Chief Financial Officer. Mr. Kuipers will remain with the Company through July 1, 2023, to help ensure a smooth transition of responsibilities.
May 03, 2023 04:01 pm ET
Omnicell to Present at the BofA Securities 2023 Healthcare Conference
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, announced that it will present at the BofA Securities 2023 Healthcare Conference on Thursday, May 11, 2023 at 8:00 a.m. PT.
May 02, 2023 04:01 pm ET
Omnicell Announces First Quarter 2023 Results
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2023.
Apr 20, 2023 02:00 pm ET
Long Island University and Omnicell Launch Center for Innovative Medication Management
Long Island University and Omnicell, Inc. (Nasdaq: OMCL) (Omnicell), a leading provider of medication management and adherence tools for health systems and pharmacies, announced the opening of the Center for Innovative Medication Management (CIMM), a state-of-the-art laboratory designed to provide an immersive pharmacy technology and analytics experience for LIU pharmacy students. Long Island University is in the top 7% of research institutions in the United States, as designated by the Carnegie Classification.
Apr 12, 2023 04:27 pm ET
Omnicell to Release First Quarter 2023 Financial Results on May 2, 2023
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2023 after market close on Tuesday, May 2, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day.
Feb 28, 2023 04:01 pm ET
Omnicell Announces Fiscal Year and Fourth Quarter 2022 Results
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for fiscal year and fourth quarter ended December 31, 2022.
Feb 16, 2023 04:01 pm ET
CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
The first sentence of the second paragraph of the release dated Feb. 15, 2023, has been corrected to replace the dial-in numbers for the earnings call on Tuesday, February 28, 2023.
Feb 15, 2023 05:10 pm ET
Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2022, after market on Tuesday, February 28, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day.
Jan 05, 2023 04:01 pm ET
Omnicell to Present at the 41st Annual J.P. Morgan Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced that they will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 8:15 a.m. Pacific Time.
Dec 05, 2022 08:01 am ET
Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it will showcase the Company’s Advanced Services at this year’s American Society of Health-System Pharmacists (ASHP) Midyear 2022 Clinical Meeting and Exhibition, to be held December 5-8, 2022 in Las Vegas.
Nov 23, 2022 04:01 pm ET
Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the upcoming investor conference:
Nov 02, 2022 08:01 am ET
Omnicell Announces Financial Results for Third Quarter 2022
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its third quarter ended September 30, 2022 and updated 2022 guidance.
Oct 13, 2022 04:01 pm ET
Omnicell to Release Third Quarter 2022 Financial Results on November 2, 2022
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter 2022, before market on Wednesday, November 2, 2022. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.
Oct 11, 2022 08:01 am ET
Omnicell Launches Specialty Pharmacy Services to Support Optimized Outpatient Medication Management and Drive Clinical and Business Outcomes for Health Systems
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell”), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced the launch of Specialty Pharmacy Services, a turnkey offering with dedicated services to set up, operate, and optimize a specialty pharmacy program.
Sep 20, 2022 04:01 pm ET
Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication management and adherence tools for health systems and pharmacies, held its 2022 Investor Day today and provided an in-depth overview of the Company’s differentiated strategy and unique business model, as well as its Advanced Services portfolio, ESG strategy, and provided more details on its long-term financial targets.
Aug 31, 2022 04:01 pm ET
Omnicell to Present at the 2022 Wells Fargo Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the upcoming investor conference:
Aug 25, 2022 04:05 pm ET
Omnicell to Host Investor Day on September 20, 2022
Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced that it will host an Investor Day on September 20, 2022 at 1:00 p.m. Eastern Time.
Aug 04, 2022 04:01 pm ET
Omnicell Announces Financial Results for Second Quarter 2022
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2022.
Jul 11, 2022 04:05 pm ET
Omnicell to Release Second Quarter 2022 Financial Results on August 4, 2022
Omnicell, Inc. (Nasdaq :OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter 2022, after market on Thursday, August 4, 2022. The Company will host a conference call and webcast to discuss its financial results at 1:30 p.m. PT that same day.
Jun 28, 2022 06:28 pm ET
Omnicell, Southwestern Energy and Ormat Technologies Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
NEW YORK, June 28, 2022 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:
Apr 28, 2022 04:01 pm ET
Omnicell Announces Financial Results for First Quarter 2022
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its first quarter ended March 31, 2022.
Apr 05, 2022 04:01 pm ET
Omnicell to Release First Quarter 2022 Financial Results on April 28, 2022
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2022, after market on Thursday, April 28, 2022. The Company will host a conference call and webcast to discuss its financial results at 1:30 p.m. PT that same day.
Mar 29, 2022 08:00 am ET
Omnicell Unveils Innovative IVX Station Robotic Compounding Technology in Winter 2022 Release
Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced the launch of IVX Station. This innovative solution is designed to scale the benefits of leveraging IV robotic technology, making it accessible to the mainstream market.
Mar 01, 2022 04:01 pm ET
Omnicell Announces Changes to Its Board of Directors
Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Jim Judson and Bruce Smith will not stand for reelection at the Company’s 2022 Annual Meeting of Stockholders. In connection with these changes, following the 2022 Annual Meeting of Stockholders, Omnicell will reduce the size of its Board to nine members.
Feb 14, 2022 04:15 pm ET
UMC Health System Partners with Omnicell for Advanced Services Solutions to Streamline Medication Management and Enhance Clinical and Operational Outcomes
Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced that UMC Health System (“UMC”) in Lubbock, Texas, has selected Omnicell’s comprehensive portfolio of Advanced Services solutions to support key pharmacy initiatives, including acute care, outpatient, retail, and 340B program strategies.
Feb 14, 2022 04:01 pm ET
Omnicell Reports Fiscal Year and Fourth Quarter 2021 Results
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its fourth quarter and fiscal year ended December 31, 2021.
Jan 05, 2022 04:01 pm ET
Omnicell to Release Fourth-Quarter and Full-Year 2021 Financial Results on February 14, 2022
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full-year 2021, after market on Monday, February 14, 2022. The Company will host a conference call and webcast to discuss its financial results at 1:30 p.m. PT that same day.
Jan 04, 2022 08:01 am ET
Omnicell Acquires MarkeTouch Media
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has acquired pharmacy software solutions provider MarkeTouch Media, LLC for total aggregate cash consideration of $82 million, subject to customary adjustments. The acquisition is expected to expand the footprint of Omnicell’s EnlivenHealthTM division across the retail pharmacy sector, while enhancing potential growth opportunities in new market segments like specialty pharmacy and pharmacy benefits management.
Dec 29, 2021 04:01 pm ET
Omnicell Completes Acquisition of ReCept
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, has completed the previously announced acquisition of ReCept Holdings, Inc. The addition of ReCept’s specialty pharmacy management services for health systems, provider groups, and federally qualified health centers (FQHCs) expands Omnicell’s Advanced Services portfolio to address the growing and complex specialty pharmacy market.
Dec 02, 2021 08:30 am ET
Omnicell to Acquire ReCept
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has entered into a definitive agreement with ReCept Holdings, Inc., a leading provider of specialty pharmacy management services for health systems, clinics, and physician groups, to acquire its business for total aggregate cash consideration of $100 million, subject to customary adjustments. The acquisition will broaden Omnicell’s portfolio of capabilities and services to address the significant need to improve access to and care coordin
Nov 22, 2021 04:05 pm ET
Omnicell to Present at Upcoming Investor Conferences
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the upcoming investor conferences:
Nov 10, 2021 08:30 am ET
Omnicell and Fresenius Kabi Collaborate to Enhance Management of Controlled Substances in U.S. Hospitals
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, and Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition, are collaborating to provide U.S. hospitals and health systems with innovative new pharmacy technology designed to support safety and efficiency in dispensing of controlled substances in patient care areas.
Nov 02, 2021 07:35 am ET
Tucson VA Medical Center Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Tucson VA Medical Center has chosen the Company’s Central Pharmacy Dispensin
Nov 02, 2021 07:30 am ET
Omnicell Announces Financial Results for Third Quarter 2021
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its third quarter ended September 30, 2021.
Oct 11, 2021 04:01 pm ET
Omnicell to Release Third Quarter 2021 Financial Results on November 2, 2021
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter of 2021 before the open of the market on Tuesday, November 2, 2021. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.
Oct 06, 2021 10:12 am ET
FDS Amplicare Hosts Webinar to Advise Pharmacists on Assisting Customers During Medicare Open Enrollment
FORT WORTH, Texas, Oct. 6, 2021 /PRNewswire/ -- FDS Amplicare, which builds industry-leading SaaS technology solutions that strengthen the health of retail pharmacies and their patients, today announced that it will host a webinar to help pharmacists learn how to assist patients in selecting the right Prescription Drug, Medicare Advantage and Medigap plans that support their healthcare and financial needs.
Sep 09, 2021 04:11 pm ET
Omnicell Completes Acquisition of FDS Amplicare
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it has completed the previously announced acquisition of FDS Amplicare. The acquisition adds a comprehensive and complementary suite of SaaS financial management, analytics, and population health solutions to Omnicell’s EnlivenHealth™ division.
Sep 06, 2021 11:27 pm ET
Omnicell Grows International Footprint with Opening of Omnicell India Software Development Center
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has opened a new software development center via its India subsidiary based in Bangalore, India. Omnicell’s new center will focus on product innovations to advance the Company’s strategy to deliver the cloud-based infrastructure to support the Autonomous Pharmacy.
Aug 18, 2021 04:31 pm ET
Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services with Summer 2021 Release
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced its latest enhancements to the Company’s industry-leading portfolio of medication management solutions. The Summer 2021 Release is designed to deliver greater process efficiency, expand automation to support medication workflows, and provide greater intelligence for workflow optimization. The release also provides greater platform deployment options, offering customers more flexibility and improving time to value for strategic initiatives.
Jul 29, 2021 08:15 am ET
Spartanburg Regional Healthcare System Partners with Omnicell to Drive Improved Clinical and Operational Outcomes
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that South Carolina-based Spartanburg Regional Healthcare System, a long-time Omnicell partner, has selected the Company’s industry-leading medication management platform to enhance efficiency, control, and safety across the care continuum.
Jul 29, 2021 08:00 am ET
Omnicell Announces Financial Results for Second Quarter 2021
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2021.
Jul 26, 2021 08:00 am ET
Omnicell to Acquire FDS Amplicare
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has entered into a definitive agreement with pharmacy software solutions provider FDS Amplicare to acquire its business for total aggregate cash consideration of $177 million, subject to customary adjustments. The acquisition will add a comprehensive and differentiated suite of financial management, analytics, and population health solutions to Omnicell’s EnlivenHealth™ division, broadening offerings that we believe will help p
Jul 12, 2021 08:31 am ET
Omnicell Appoints Edward Bousa to Board of Directors
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has increased its number of board seats from 9 to 10, and has appointed Edward P. Bousa to fill the newest seat of the Company’s Board of Directors, effective immediately. Mr. Bousa will serve as an independent director and as a member of the Board’s Corporate Governance Committee.
Jul 12, 2021 08:01 am ET
Omnicell to Release Second Quarter 2021 Financial Results on July 29, 2021
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter of 2021 before the open of the market on Thursday, July 29, 2021. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.
Jul 07, 2021 08:00 am ET
Chartwell Enhances IV Preparations with Omnicell® IVX Workflow
Chartwell Pennsylvania, LP, the nation’s leading health-system based provider of home infusion, specialty pharmacy, and enteral nutrition, has partnered with
Apr 29, 2021 04:46 pm ET
Scripps Health Selects Omnicell Medication Management Solutions to Help Improve Clinical and Operational Efficiency
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Scripps Health has selected the Company’s industry-leading medication management platform to improve pharmacy supply chain management across its San Diego-based network.
Apr 29, 2021 04:01 pm ET
Omnicell Announces Financial Results for First Quarter 2021
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its first quarter ended March 31, 2021.
Apr 27, 2021 08:01 am ET
EnlivenHealth Partners With Twilio to Accelerate Launch of Transformative Patient Communications Solutions
Omnicell, Inc., (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that its EnlivenHealth™ division is partnering with Twilio, the leading cloud communications and customer engagement platform, to accelerate the creation and launch of breakthrough patient engagement solutions designed to transform the practice and business of retail pharmacy. Studies have shown that better patient engagement and communications produce measurably better patient adherence and health outcomes, leading to increased patient ret
Apr 07, 2021 08:01 am ET
Aultman Health Foundation to Enhance Medication Management with Omnicell’s Central Pharmacy Dispensing Service
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Aultman Health Foundation, a long-term sole source Omnicell partner, has selected the Company’s cloud-based solutions and technology-enabled services to enhance safety and efficiency in central pharmacy and point-of-care dispensing.
Apr 01, 2021 04:05 pm ET
Omnicell to Release First Quarter 2021 Financial Results on April 29, 2021
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter of 2021 after the close of the market on Thursday, April 29, 2021. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day.
Mar 03, 2021 08:01 am ET
The Christ Hospital Health Network Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced continued growth for the Company’s cloud-based solutions and technology-enabled services as it continues to drive market adoption of the Autonomous Pharmacy vision.
Feb 22, 2021 08:30 am ET
Omnicell Appoints Christine Mellon as Chief People Officer
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Christine Mellon has joined the company as Executive Vice President, Chief People Officer. Bringing more than 25 years of human resources, organizational, and cultural transformation leadership, Ms. Mellon will lead human resources functions, employee environments, and internal communications for Omnicell’s global operations.
Feb 12, 2021 04:01 pm ET
Omnicell to Present at Upcoming Investor Conferences
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences:
Feb 01, 2021 04:01 pm ET
Omnicell Reports Fiscal Year and Fourth Quarter 2020 Results
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its fiscal year and fourth quarter ended December 31, 2020.
Jan 26, 2021 04:01 pm ET
WVU Medicine Selects Omnicell One Intelligence Solution to Drive Better Pharmacy Inventory Management, Optimize Costs, and Support Better Patient Care
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that WVU Medicine has expanded their partnership with Omnicell through a 10-year, sole source agreement renewal, with plans to leverage the Company’s industry-leading medication inventory management platform to improve pharmacy supply chain management across the West Virginia-based health network.
Jan 13, 2021 08:01 am ET
Omnicell Announces Preliminary Fiscal Year 2020 Financial Results
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced preliminary financial results for its fiscal year ended December 31, 2020 and provided full year 2021 guidance. For 2020, the Company expects to exceed its pre-pandemic product bookings guidance and also expects to exceed its October 2020 guidance across all key metrics, including revenues, total product bookings and non-GAAP earnings per share.
Jan 11, 2021 08:00 am ET
Omnicell's EnlivenHealth™ Reports Strong Customer Demand for New SaaS Technology Solution to Help Pharmacies Meet COVID-19 Vaccination Challenges
Omnicell, Inc., (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced strong market demand for its new CareScheduler digital solution that enables pharmacies to efficiently and effectively manage administration of the COVID-19 vaccine. CareScheduler was developed by EnlivenHealth™, the Omnicell division that provides patient engagement and communications technology solutions for retail pharmacies and health plans.
Jan 04, 2021 08:00 am ET
Omnicell to Partner with Guy’s and St Thomas’ NHS Foundation Trust, London on Development of European Technology-Enabled Intelligence Centre as Part of Expansion of Omnicell Systems Across the South E
Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and supply chain solutions for health systems, today announced its intent to enter a new partnership with Guy’s and St Thomas’ NHS Foundation Trust, London to develop technology-enabled inventory optimization and intelligence services.
Dec 21, 2020 04:30 pm ET
Owensboro Health to Deploy Omnicell’s Technology-Enabled Services to Improve Safety and Efficiency in Medication Management
Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Kentucky-based Owensboro Health, a long-term sole source partner, will expand their medication management automation platform to central pharmacy operations with Omnicell’s Central Pharmacy Dispensing Service.
Dec 15, 2020 05:02 pm ET
Omnicell to Present at the J.P. Morgan 39th Annual Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences:
Dec 09, 2020 08:31 am ET
Thinking about trading options or stock in Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp?
NEW YORK, Dec. 9, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARCT, BA, AMD, OMCL, and CCL.
Nov 11, 2020 08:01 am ET
New National Survey Finds the Majority of Retail Pharmacies and Health Plans Are Concerned About People Actually Taking the COVID-19 Vaccine Once It’s Available
EnlivenHealth™, a division of Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced the findings of a new national survey which found that 67% of pharmacies and 99% of health plans responding to the survey are either “very concerned” or “somewhat concerned” about people’s willingness to take the COVID-19 vaccine once it is available. Responding to the COVID-19 pandemic, 77% of pharmacies who took part in the EnlivenHealth™ survey said they would either be adopting or expanding year-round v
Nov 10, 2020 08:01 am ET
Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services at Omnicell Illuminate 2020
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced latest innovations to the Company’s industry-leading portfolio of medication management solutions. These powerful new capabilities are designed to help hospitals and health systems expand their medication inventory visibility and supply chain management capabilities, supporting improved clinical, operational, and financial goals.
Nov 09, 2020 08:01 am ET
Allegheny Health Network Partners with Omnicell to Drive Safety and Efficiency for Medication Management Across Western Pennsylvania Network
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management and supply chain solutions for health systems, today announced a new partnership with Allegheny Health Network (AHN), to provide central pharmacy dispensing and medication management at the point of care across the network’s 13 hospital locations in western Pennsylvania.
Nov 06, 2020 05:27 pm ET
Omnicell to Present at Upcoming Investor Conferences
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences:
Oct 27, 2020 04:01 pm ET
Omnicell Reports Third Quarter 2020 Results
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its third quarter ended September 30, 2020.
Oct 22, 2020 08:01 am ET
Lehigh Valley Health Network Chooses Omnicell Solutions to Enhance Clinical and Operational Outcomes and Streamline Medication Management
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Pennsylvania-based Lehigh Valley Health Network (LVHN) will be leveraging Omnicell’s industry-leading medication management platform of solutions to enhance efficiency, control, and safety of medication management.
Oct 20, 2020 08:01 am ET
Memorial Hospital at Gulfport Selects Omnicell Central Pharmacy Dispensing Service to Enhance Medication Safety and Dispensing Efficiency
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Memorial Hospital at Gulfport, a Mississippi-based, not-for-profit hospital, has chosen the Company’s Central Pharmacy Dispensing Service, part of the industry-leading medication management platform, to support their pharmacy operations.
Oct 06, 2020 08:00 am ET
Omnicell Launches EnlivenHealth™ to Aid Retail Pharmacies and Health Plans In Improving Patient Adherence, Quality Measures, and Retention
Omnicell, Inc., (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it is launching EnlivenHealth™, a division dedicated to enabling retail pharmacies and health plans to improve patient outcomes while reducing costs through innovative Software-as-a-Service (SaaS) technology solutions. Formerly known as Omnicell Population Health Solutions, EnlivenHealth™ serves many of the nation’s leading retail pharmacy brands and health plan organizations.
Oct 01, 2020 04:01 pm ET
Omnicell Completes Acquisition of Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it has completed the previously announced acquisition of Pharmaceutical Strategies Group’s (PSG) 340B Link business, pursuant to the terms and conditions of an Equity Purchase Agreement. The acquisition adds a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savings on outpatient pres
Sep 29, 2020 04:53 pm ET
Omnicell to Release Third Quarter 2020 Earnings Results on October 27, 2020
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, October 27, 2020, to discuss the Company’s Third Quarter 2020 financial results.
Sep 23, 2020 06:45 am ET
Omnicell, Inc. Prices $500 Million 0.25% Convertible Senior Notes Offering (up 37.5% Conversion Premium)
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced today the pricing of $500 million aggregate principal amount of 0.25% Convertible Senior Notes due 2025 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).
Sep 22, 2020 07:00 am ET
Omnicell Announces Proposed Private Placement of $500 Million of Convertible Senior Notes
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes due 2025 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Omnicell also intends to grant the initial purchasers of the notes an option to purchase, within a 13-day pe
Sep 01, 2020 04:15 pm ET
Omnicell to Present at Upcoming Investor Conferences
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the following upcoming investor conferences:
Aug 17, 2020 08:00 am ET
Peninsula Regional Medical Center Extends Partnership With Omnicell to Enhance Safety and Efficiency in Sterile Compounding
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Maryland-based Peninsula Regional Medical Center has chosen the Company’s industry-leading medication management platform to support their in-house sterile compounding operations.
Aug 12, 2020 08:00 am ET
Omnicell to Acquire Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has entered into a definitive agreement with Pharmaceutical Strategies Group (PSG) to acquire its 340B Link business for total aggregate cash consideration of $225 million, subject to customary adjustments. The acquisition will add a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savi
Jul 28, 2020 04:01 pm ET
Omnicell Reports Second Quarter 2020 Results
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2020.
Jul 21, 2020 04:01 pm ET
Omnicell to Release Second Quarter 2020 Earnings Results on July 28, 2020
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, July 28, 2020, to discuss the Company’s Second Quarter 2020 financial results.
Jul 20, 2020 08:00 am ET
Omnicell Streamlines Pharmacy Supply Chain Through Cloud-Based Predictive Intelligence Solution
Omnicell, Inc., (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, continues to deliver innovation that supports the fully Autonomous Pharmacy through the launch of Omnicell One™, a predictive pharmacy intelligence solution that will
May 07, 2020 04:01 pm ET
Omnicell Reports First Quarter 2020 Results
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its first quarter ended March 31, 2020.
May 01, 2020 04:05 pm ET
Omnicell to Hold Virtual 2020 Annual Meeting of Stockholders
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that due to the public health impact of the novel coronavirus (COVID-19) pandemic and to protect the health and wellbeing of its employees, stockholders and the broader community, the Company will hold its 2020 Annual Meeting of Stockholders in a virtual meeting format only, via live audio webcast. The virtual Annual Meeting will be held as planned on Tuesday, May 26, 2020 at 1:30 pm PT. Stockholders will not be able to attend in person
Apr 28, 2020 04:05 pm ET
Omnicell to Release First Quarter 2020 Earnings Results on May 7, 2020
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, May 7, 2020, to discuss the Company’s First Quarter 2020 financial results.
Feb 10, 2020 08:00 am ET
Geisinger Optimizes Hospital Efficiency and Safety with Continued Investment in Omnicell XT Series Automated Dispensing Systems
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Geisinger, one of the leading health systems serving Pennsylvania and New Jersey, has partnered with Omnicell to help drive clinical and operational efficiency, increase medication safety and reduce costs—ultimately supporting enhanced patient care.
Feb 06, 2020 04:01 pm ET
Omnicell Reports Fiscal Year and Fourth Quarter 2019 Results
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its fiscal year and fourth quarter ended December 31, 2019.
Feb 03, 2020 08:01 am ET
Omnicell Enhances Robotic IV Insourcing Offerings and Ramps up Investment in IV Automation Technology
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced significant clinical enhancements and expansion of the Company’s unique IV compounding service, which combines advanced technology, clinical expertise, operational support, and workflow/analytics to address challenges in sterile compounding.
Jan 30, 2020 04:05 pm ET
Omnicell to Release Fourth Quarter 2019 Earnings Results on February 6, 2020
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 6, 2020, to discuss the Company’s Fourth Quarter 2019 financial results.
Jan 28, 2020 08:00 am ET
Multiple Health Systems Help Optimize Efficiency and Patient Safety by Adopting Omnicell’s Point of Care Automated Workflow Technology
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that a number of leading-edge health systems across North America are adopting the Company’s point-of-care automated workflow technology. Health systems like Duke University
Jan 26, 2020 11:00 pm ET
Omnicell Showcases Latest Advancements to Medication Management Portfolio at Arab Health Exhibition and Congress
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced the Company will be showcasing the latest advancements to its medication management portfolio at the Arab Health Exhibition and Congress from 27-30 January in Dubai. Arab Health is the largest gathering of healthcare and trade professionals in the Middle East region.
Jan 21, 2020 08:00 am ET
Allegheny General Hospital Partners with Omnicell to Automate Sterile Compounding
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Allegheny General Hospital, Pittsburgh, Pa., part of Allegheny Health Network (AHN), has selected Omnicell’s Central Pharmacy IV Compounding Service, a comprehensive, turnkey approach for insourcing some sterile compounding operations.
Dec 18, 2019 08:21 am ET
Omnicell to Present at the 38th Annual J.P. Morgan Healthcare Conference
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps, founder, chairman, president and CEO, and Peter Kuipers, executive vice president and CFO, will be presenting at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, CA.
Dec 10, 2019 09:00 am ET
Omnicell to Present Strategic Priorities and Long-Term Financial Targets at Annual Innovation Day for Investors and Analysts
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today is hosting its 2019 Investor and Analyst Day at the Annual ASHP Midyear Meeting in Las Vegas, Nevada. Randall Lipps, Founder, Chairman, President and CEO, and Peter Kuipers, Executive Vice President and Chief Financial Officer, and other members of the management team will provide an update on Omnicell’s strategic priorities and select five-year financial targets.
Dec 09, 2019 08:01 am ET
Omnicell and Huron to Provide Outcome-Based Professional Services
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, is partnering with Huron, a global professional services firm, to provide project implementation and change management services for customers adopting Omnicell technology.
Dec 09, 2019 08:01 am ET
Omnicell and Kit Check Partner to Offer Cloud-based Solution for Tracking of Controlled Substances
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, has entered into an agreement with Kit Check™ to offer Bluesight™ for Controlled Substances diversion prevention software, helping customers to gain better visibility of controlled substances across the pharmacy supply chain.
Dec 05, 2019 08:01 am ET
Omnicell to Unveil Latest Advancements to Its Medication Management Solution Portfolio in Automation, Intelligence, and Services at 2019 ASHP Midyear Meeting
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that it will showcase the Company’s latest advancements to its medication management solution portfolio at this year’s American Society of Health-System Pharmacists 2019 Midyear Meeting, to be held in Las Vegas from December 7-11, 2019. Omnicell’s new innovations and service capabilities advance the Company’s vision for the autonomous pharmacy, a roadmap to help improve patient outcomes and operational efficiencies.
Nov 19, 2019 04:01 pm ET
Omnicell Announces Annual Innovation Day for Investors and Analysts
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced they will host an Investor and Analyst meeting at the Annual ASHP Midyear Meeting on December 10, 2019.
Oct 24, 2019 04:01 pm ET
Omnicell Achieves Record Revenue in the Third Quarter 2019
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its third quarter ended September 30, 2019.
Oct 21, 2019 08:01 am ET
Med Center Health Formalizes Partnership With Omnicell to Drive Efficiency With Automated Medication Management
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Med Center Health has signed a sole source agreement to partner with Omnicell to streamline and secure its medication management process. The health system will upgrade to
Oct 17, 2019 04:01 pm ET
Omnicell to Release Third Quarter 2019 Earnings Results on October 24, 2019
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, October 24, 2019, to discuss the Company’s Third Quarter 2019 financial results.
Oct 17, 2019 08:01 am ET
Mercy Selects Omnicell to Automate and Digitize Medication Management
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Mercy, one of the top five U.S. health systems that serves Arkansas, Kansas, Missouri and Oklahoma, will support medication management across its service network through Omnicell automation and intelligence solutions.
Oct 08, 2019 08:01 am ET
Salem Health Partners With Omnicell to Help Improve Nursing and Pharmacy Efficiency and Enhance Patient Safety
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Salem Health Hospitals & Clinics has partnered with Omnicell to improve safety and efficiency in their medication management processes through the Company’s automation and intelligence solutions at their flagship Salem Hospital, in Salem, Ore.
Oct 06, 2019 10:00 am ET
Bragar Eagel & Squire is Investigating Certain Officers and Directors of National General Holdings, Natural Health Trends, Omnicell, and Polarity TE and Encourages Investors to Contact the Firm
Bragar Eagel & Squire is investigating certain officers and directors of National General Holdings Corp. (NASDAQ: NGHC), Natural Health Trends Corp. (NASDAQ: NHTC), Omnicell, Inc. (NASDAQ: OMCL), and PolarityTE, Inc. (NASDAQ: PTE) on behalf of...
Sep 15, 2019 10:50 pm ET
OMNICELL 24 HOUR DEADLINE ALERT: APPROXIMATELY 24 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Omnicell, Inc.
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until September 16, 2019 to file lead plaintiff applications in a...
Sep 13, 2019 10:50 pm ET
OMNICELL 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Omnicell, Inc.
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until September 16, 2019 to file lead plaintiff applications in a securities class action lawsuit against Omnicell, Inc. (NasdaqGS: OMCL). Investor losses must relate to purchases of the Company’s securities between October 25, 2018 and July 11, 2019. This action is pending in the United States District Court for the Northern District of California.
Sep 13, 2019 06:32 pm ET
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Omnicell, Inc. (NASDAQ: OMCL) and Encourages Omnicell Investors to Contact the Firm
NEW YORK, Sept. 13, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all investors that purchased Omnicell, Inc. (NASDAQ: OMCL) securities between October 25, 2018 and July 11,2019 (the "Class Period").  Investors have until September 16, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Sep 13, 2019 04:13 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Omnicell, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL) of the September 16, 2019 deadline to seek the role of lead plaintiff in a federal securities class...
Sep 13, 2019 03:00 pm ET
DEADLINE ALERT - Omnicell, Inc. (OMCL) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Deadline: September 16, 2019
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL) and certain of its officers, on behalf of shareholders who...
Sep 12, 2019 03:29 pm ET
CLASS ACTION UPDATE for OMCL, CURLF, PS and WFTIQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Sep 12, 2019 02:55 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL
Pomerantz LLP is investigating claims on behalf of investors of  Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Sep 12, 2019 10:00 am ET
DEADLINE ALERT - Omnicell, Inc. (OMCL) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Deadline: September 16, 2019
NEW YORK, Sept. 12, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Omnicell, Inc. ("Omnicell" or the "Company") (NASDAQ: OMCL) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Omnicell securities between October 25, 2018 and July 11, 2019, both dates inclusive. Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/omcl.  
Sep 12, 2019 09:32 am ET
SHAREHOLDER ALERT: OMCL KPTI NTAP TXT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 11, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS JE, MDP, MMM, OMCL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Omnicell, Inc. (OMCL) Class Period: 10/25/2018 -...
Sep 11, 2019 04:40 pm ET
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Omnicell, Inc.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 16, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL) investors who...
Sep 11, 2019 01:31 pm ET
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Omnicell, Inc.
Law Offices of Howard G. Smith reminds investors of the upcoming September 16, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL)...
Sep 11, 2019 09:29 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OMCL, LB, JE and NTAP
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 10, 2019 07:30 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Omnicell, Ideanomics, Eagle Bancorp, and Karyopharm and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Omnicell, Inc. (NASDAQ: OMCL), Ideanomics, Inc. (NASDAQ: IDEX), Eagle Bancorp,  Inc. (NASDAQ: EGBN), and Karyopharm...
Sep 10, 2019 02:32 pm ET
NATIONALLY RANKED ROSEN LAW FIRM Reminds Omnicell, Inc. Investors of Important September 16th Deadline in Securities Class Action; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT THE FI
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Omnicell, Inc. (NASDAQ: OMCL) from October 25, 2018 through April 9, 2019, inclusive (the “Class Period”) of the important September 16, 2019 lead plaintiff...
Sep 10, 2019 09:38 am ET
CLASS ACTION UPDATE for OMCL, KPTI, CURLF and TWOU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Sep 09, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS JE, MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Reckitt Benckiser Group plc (RBGLY)Class Period: 7/28/2014 - 4/9/2019Lead Plaintiff Motion Deadline:...
Sep 09, 2019 12:44 pm ET
OMCL, JE, and IDEX CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in OMCL, JE, and IDEX of Filing Deadlines
Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of OMCL, JE, and IDEX. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead...
Sep 06, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Reckitt Benckiser Group plc (RBGLY)Class Period:...
Sep 06, 2019 09:38 am ET
SHAREHOLDER ALERT: RLGY OMCL CARB NTAP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 05, 2019 03:27 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL
Pomerantz LLP is investigating claims on behalf of investors of  Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Sep 05, 2019 09:55 am ET
SHAREHOLDER ALERT: OMCL IFF NTAP CVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 04, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CTST, MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: CannTrust Holdings, Inc. (CTST) Class Period: 11/14/2018 - 7/12/2019Lead Plaintiff Motion Deadline:...
Sep 04, 2019 03:00 pm ET
RBGLY, OMCL & IDEX Class Action Update - Bronstein, Gewirtz & Grossman, LLC
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Sep 04, 2019 12:39 pm ET
RLGY, NFLX, OMCL, CARB CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in RLGY, NFLX, OMCL, and CARB of Filing Deadlines
Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of RLGY, NFLX, OMCL, and CARB. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A...
Sep 04, 2019 09:33 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of INS, OMCL, KPTI and CAH
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 03, 2019 11:35 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Omnicell, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - September 3, 2019) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Omnicell, Inc. (NASDAQ: OMCL) ("Omnicell" or the "Company") of the September 16, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Sep 03, 2019 10:30 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Realogy, Reckitt Benckiser, and Omnicell and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Realogy Holdings Corporation (NYSE: RLGY), Reckitt Benckiser Group Plc (Other OTC: RBGLY), and Omnicell, Inc. (NASDAQ: OMCL)....
Sep 03, 2019 08:10 pm ET
Hagens Berman Reminds Omnicell (OMCL) Investors of September 16, 2019 Lead Plaintiff Deadline, Investors Who Lost $50,000+ May Contact the Firm
Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ: OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a federal securities class action pending against the Company. If you invested in Omnicell between October 25, 2018...
Sep 03, 2019 09:44 am ET
CLASS ACTION UPDATE for OMCL, NGHC, IFF and NTAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Sep 02, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CTST, MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: CannTrust Holdings, Inc. (CTST) Class Period:...
Sep 01, 2019 02:00 pm ET
ROSEN, A HIGHLY RANKED LAW FIRM, Reminds Omnicell, Inc. Investors of Important Deadline in Securities Class Action – OMCL
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Omnicell, Inc. (NASDAQ: OMCL) from October 25, 2018 through April 9, 2019, inclusive (the “Class Period”) of the important September 16, 2019 lead plaintiff...
Aug 30, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CTST, MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: CannTrust Holdings, Inc. (CTST) Class Period: 11/14/2018 - 7/12/2019Lead Plaintiff Motion Deadline:...
Aug 30, 2019 03:00 pm ET
VERB, RBGLY & OMCL - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Upcoming Class Actions
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Aug 30, 2019 11:38 am ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Omnicell, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL) of the September 16, 2019 deadline to seek the role of lead plaintiff in a federal securities class...
Aug 29, 2019 01:10 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL
Pomerantz LLP is investigating claims on behalf of investors of  Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Aug 29, 2019 09:26 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OMCL, NFLX, EGBN and IFF
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Aug 28, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CTST, MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: CannTrust Holdings, Inc. (CTST) Class Period:...
Aug 28, 2019 08:06 pm ET
OMCL Litigation Deadline: Hagens Berman Reminds Omnicell (OMCL) Investors of September 16, 2019 Lead Plaintiff Deadline, Encourages Investors Who Lost $50,000+ to Contact the Firm
Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ: OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a federal securities class action pending against the Company. If you invested in Omnicell between October 25, 2018...
Aug 27, 2019 04:01 pm ET
Omnicell to Present at the 2019 Wells Fargo Securities Healthcare Conference
Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps, founder, chairman, president and CEO, and Peter Kuipers, executive vice president and CFO, will be presenting at the 2019 Wells Fargo Securities Healthcare Conference at the Westin Copley Place, Boston, MA.
Aug 27, 2019 12:31 pm ET
RLGY, NFLX, OMCL, CARB CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in RLGY, NFLX, OMCL, and CARB of Filing Deadlines
Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of RLGY, NFLX, OMCL, and CARB. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A...
Aug 27, 2019 09:58 am ET
CLASS ACTION UPDATE for OMCL, MNK, PS and TWOU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Aug 26, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CTST, MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: CannTrust Holdings, Inc. (CTST) Class Period: 11/14/2018 - 7/12/2019Lead Plaintiff Motion Deadline:...
Aug 26, 2019 10:13 pm ET
Zhang Investor Law Reminds Investors of Sept. 16 Deadline in Securities Class Action Lawsuit Against Omnicell, Inc. – OMCL
Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Omnicell, Inc. (NASDAQ: OMCL) from October 25, 2018 through April 9, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover...
Aug 26, 2019 07:40 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Reckitt Benckiser, Omnicell, Ideanomics, and Eagle Bancorp and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Reckitt Benckiser Group Plc (Other OTC: RBGLY), Omnicell, Inc. (NASDAQ: OMCL), Ideanomics, Inc. (NASDAQ: IDEX), and Eagle...
Aug 25, 2019 10:52 am ET
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In OMCL, DEX, NFLX or KPTI To Contact The Firm
New York, New York--(Newsfile Corp. - August 25, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, encourages investors in the following companies to contact the firm:
Aug 24, 2019 10:45 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL
NEW YORK, Aug. 24, 2019 /CNW/ -- Pomerantz LLP is investigating claims on behalf of investors of Omnicell, Inc. ("Omnicell" or the "Company") (NASDAQ: OMCL). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
Aug 24, 2019 10:45 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL
NEW YORK, Aug. 24, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Omnicell, Inc. ("Omnicell" or the "Company") (NASDAQ: OMCL). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
Aug 23, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CTST, MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: CannTrust Holdings, Inc. (CTST)Class Period:...
Aug 22, 2019 09:50 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OMCL, CURLF, GVA and VAL
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Aug 22, 2019 08:00 am ET
Omnicell Launches Autonomous Pharmacy Vision for Retail Pharmacies at NACDS
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions, including adherence tools for pharmacies, healthcare systems, and health plans, will roll out its vision of the Autonomous Pharmacy to retail pharmacies during the National Association of Chain Drug Stores (NACDS) Total Store Expo, taking place at the Boston Convention Center on August 24-26, 2019.
Aug 21, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Reckitt Benckiser Group plc (RBGLY)Class Period: 7/28/2014 - 4/9/2019Lead Plaintiff Motion Deadline:...
Aug 21, 2019 09:45 am ET
CLASS ACTION UPDATE for OMCL, NFLX, GVA and TWOU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Aug 20, 2019 08:06 pm ET
Hagens Berman Reminds Omnicell (OMCL) Investors of Lead Plaintiff Deadline, Encourages Investors Who Lost $50,000+ to Contact the Firm
Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ: OMCL) of the September 16, 2019 deadline to move for lead plaintiff in the securities class action, Bursick v. Omnicell, Inc. et al., No. 3:19cv04150, pending in the U.S. District Court for...
Aug 20, 2019 03:30 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL
Pomerantz LLP is investigating claims on behalf of investors of  Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Aug 20, 2019 10:17 am ET
RLGY, NFLX, OMCL, CARB CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in RLGY, NFLX, OMCL, and CARB of Filing Deadlines
Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of RLGY, NFLX, OMCL, and CARB. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A...
Aug 19, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS MMM, OMCL, RBGLY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Reckitt Benckiser Group plc (RBGLY)Class Period:...
Aug 19, 2019 09:29 am ET
SHAREHOLDER ALERT: STG OMCL GVA NTAP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Aug 18, 2019 07:30 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CannTrust, Realogy, Reckitt Benckiser, and Omnicell and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of CannTrust Holdings, Inc. (NYSE: CTST), Realogy Holdings Corporation (NYSE: RLGY), Reckitt Benckiser Group Plc (Other OTC:...
Aug 16, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS EVH, OMCL, RBGLY, TWOU INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Reckitt Benckiser Group plc (RBGLY)Class Period: 7/28/2014 - 4/9/2019Lead Plaintiff Motion Deadline:...
Aug 16, 2019 03:00 pm ET
VERB, RBGLY & OMCL - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Aug 16, 2019 01:55 pm ET
Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Omnicell, Inc. – OMCL
Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Omnicell, Inc. (NASDAQ: OMCL) from October 25, 2018 through April 9, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover...
Aug 15, 2019 05:29 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL
Pomerantz LLP is investigating claims on behalf of investors of  Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Aug 15, 2019 11:26 am ET
CLASS ACTION UPDATE for RBGLY, OMCL, GVA and NTAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Aug 14, 2019 10:50 pm ET
OMNICELL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against O
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 16, 2019 to file lead plaintiff applications in a securities class action lawsuit against...
Aug 14, 2019 09:47 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BUD, OMCL, EGBN and GTT
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Aug 14, 2019 09:00 am ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Omnicell, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - August 14, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Omnicell, Inc. (NASDAQ: OMCL) ("Omnicell" or the "Company") of the September 16, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Aug 13, 2019 09:44 am ET
SHAREHOLDER ALERT: ZUO OMCL LB CAH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Aug 12, 2019 10:50 pm ET
OMNICELL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Omnicell, Inc. - OMCL
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 16, 2019 to file lead plaintiff applications in a securities class action lawsuit against Omnicell, Inc. (NasdaqGS: OMCL), if they purchased the...
Aug 12, 2019 02:24 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Omnicell, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL) of the September 16, 2019 deadline to seek the role of lead plaintiff in a federal securities class...
Aug 12, 2019 09:03 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MMM, RBGLY, OMCL and EGBN
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Aug 11, 2019 07:29 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CannTrust, Realogy, Reckitt Benckiser, and Omnicell and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of CannTrust Holdings, Inc. (NYSE: CTST), Realogy Holdings Corporation (NYSE: RLGY), Reckitt Benckiser Group Plc (Other OTC:...
Aug 09, 2019 10:50 pm ET
OMNICELL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against O
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 16, 2019 to file lead plaintiff applications in a securities class action lawsuit against...
Aug 09, 2019 04:38 pm ET
CLASS ACTION UPDATE for OMCL, MNK and EVH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Aug 09, 2019 03:37 pm ET
ROSEN, A TOP RANKED LAW FIRM, Reminds Omnicell, Inc. Investors of Important Deadline in Securities Class Action – OMCL
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Omnicell, Inc. (NASDAQ: OMCL) from October 25, 2018 through April 9, 2019, inclusive (the “Class Period”) of the important September 16, 2019 lead plaintiff...
Aug 08, 2019 09:55 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BUD, CTST, OMCL and KPTI
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Aug 07, 2019 10:50 pm ET
OMNICELL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Omnicell, Inc. - OMCL
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 16, 2019 to file lead plaintiff applications in a securities class action lawsuit against Omnicell, Inc. (NasdaqGS: OMCL), if they purchased the...
Aug 07, 2019 08:11 pm ET
OMCL CLASS ACTION REMINDER: Hagens Berman Reminds Omnicell (OMCL) Investors of September 16, 2019 Lead Plaintiff Deadline; Investors Who Lost $50,000+ May Contact the Firm
Hagens Berman Sobol Shapiro LLP reminds investors in Omnicell, Inc. (NASDAQ: OMCL) of the September 16, 2019 Lead Plaintiff deadline in the securities class action, Bursick v. Omnicell, Inc. et al., No. 3:19-cv-04150, pending in the U.S. District...
Aug 07, 2019 02:01 pm ET
CLASS ACTION UPDATE for CTST, OMCL, LB and ABMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Aug 06, 2019 03:15 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Omnicell, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL) of the September 16, 2019 deadline to seek the role of lead plaintiff in a federal securities class...
Aug 06, 2019 09:37 am ET
SHAREHOLDER ALERT: DBD OMCL NFLX KPTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Aug 05, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BUD, EROS, OMCL, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Anheuser-Busch InBev SA/NV (BUD) Class Period:...
Aug 05, 2019 06:34 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL
Pomerantz LLP is investigating claims on behalf of investors of  Omnicell, Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.